| Godavari Drugs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530317 |
NSE Symbol : - |
P/E(TTM) : 31.53 |
|
ISIN Demat : INE362C01012 |
Div & Yield% : 0.00 |
EPS(TTM) : 3.56 |
|
Book Value(₹) : 71.05 |
Market Cap(₹Cr) : 122.51 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 27.96 | 33.16 | 22.18 | 26.65 | 23.81 | 25.50 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 27.96 | 33.16 | 22.18 | 26.65 | 23.81 | 25.50 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.15 | 0.25 | 0.27 | 0.64 | 0.01 | 0.11 |
| Total Income | 28.11 | 33.41 | 22.45 | 27.28 | 23.82 | 25.61 |
| Total Expenditure | 25.44 | 30.22 | 19.71 | 24.65 | 20.91 | 22.39 |
| PBIDT | 2.67 | 3.19 | 2.75 | 2.63 | 2.91 | 3.22 |
| Interest | 0.90 | 0.96 | 1.11 | 0.91 | 1.00 | 1.11 |
| PBDT | 1.77 | 2.23 | 1.63 | 1.73 | 1.91 | 2.11 |
| Depreciation | 0.59 | 0.61 | 0.61 | 0.60 | 0.60 | 0.67 |
| Tax | 0.07 | 0.33 | 0.26 | 0.12 | 0.26 | 0.55 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 1.11 | 1.29 | 0.76 | 1.00 | 1.04 | 0.89 |
| Extra-ordinary Items | 0.00 | 0.08 | 0.19 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.11 | 1.21 | 0.57 | 1.00 | 1.04 | 0.89 |
| EPS (Unit Curr.) | 1.10 | 1.71 | 1.01 | 1.33 | 1.38 | 1.19 |
| EPS (Adj) (Unit Curr.) | 1.10 | 1.71 | 1.01 | 1.33 | 1.38 | 1.19 |
| Calculated EPS (Unit Curr.) | 1.10 | 1.27 | 1.01 | 1.33 | 1.38 | 1.19 |
| Calculated EPS (Adj) (Unit Curr.) | 1.10 | 1.27 | 1.01 | 1.33 | 1.38 | 1.19 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.38 | 5.10 | 4.02 | 5.32 | 5.53 | 4.74 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.38 | 5.10 | 4.02 | 5.32 | 5.53 | 4.74 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.13 | 10.13 | 7.53 | 7.53 | 7.53 | 7.53 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 9.55 | 9.62 | 12.40 | 9.87 | 12.22 | 12.63 |
| PBDTM(%) | 6.33 | 6.72 | 7.35 | 6.49 | 8.02 | 8.27 |
| PATM(%) | 3.97 | 3.89 | 3.43 | 3.75 | 4.37 | 3.49 |
